Pay in 4 interest-free payments of $39.75 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Trastuzumab deruxtecan (DS-8201a) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC)
It is suggested that inhibition of this pathway may be a novel therapeutic approach to combat obesity
Tirzepatide is a synthetic peptide with glucose-lowering effects
coli O55:B5 activates TLR-4 of immune cells
TT-200-SC Block, 12 x 15mm, 95.5 x 76.5 x 50mm 179324-69-7 Trastuzumab deruxtecan (DS-8201a) is anBlock for Sample Concentrator TT 200 SC, 12 x 15mm, 95. 5 x 76. 5 x 50mm
US$ 7400.00
US$ 2950.00
US$ 6600.00
US$ 7400.00
US$ 600.00
US$ 5850.00
US$ 4200.00
US$ 7400.00
US$ 2950.00
US$ 1250.00
US$ 1250.00
US$ 9150.00
US$ 6600.00
US$ 3000.00
US$ 1450.00
US$ 1950.00